Evidence map›Paper›PMID 27672102›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2017

Systemic Age-Associated DNA Hypermethylation of ELOVL2 Gene: In Vivo and In Vitro Evidences of a Cell Replication Process.

Maria Giulia Bacalini, Joris Deelen, Chiara Pirazzini, Marco De Cecco, Cristina Giuliani, Catia Lanzarini, Francesco Ravaioli, Elena Marasco, Diana van Heemst, H Eka D Suchiman and 14 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. A Sex-Specific Minimal CpG-Based Model for Biological Aging UsingInternational journal of molecular sciences · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Diagnostics (Basel, Switzerland) · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 7 institutions in 3 countries.

Maria Giulia BacaliniDepartment of Experimental, Diagnostic and Specialty Medicine.
Joris DeelenDepartment of Molecular Epidemiology, Leiden University Medical Center, The Netherlands.
Chiara PirazziniDepartment of Experimental, Diagnostic and Specialty Medicine.
Marco De CeccoDepartment of Molecular Biology, Cell Biology and Biochemistry, Center for Genomics and Proteomics, Brown University, Providence, Rhode Island.
Cristina GiulianiDepartment of Biological, Geological and Environmental Sciences.
Catia LanzariniDepartment of Experimental, Diagnostic and Specialty Medicine.
Francesco RavaioliDepartment of Experimental, Diagnostic and Specialty Medicine.
Elena MarascoDepartment of Experimental, Diagnostic and Specialty Medicine.
Diana van HeemstDepartment of Molecular Epidemiology, Leiden University Medical Center, The Netherlands.
H Eka D SuchimanDepartment of Molecular Epidemiology, Leiden University Medical Center, The Netherlands.
Roderick SliekerDepartment of Molecular Epidemiology, Leiden University Medical Center, The Netherlands.
Enrico GiampieriDepartment of Physics and Astronomy, University of Bologna, Italy.
Rina RecchioniCenter of Clinical Pathology and Innovative Therapy, INRCA-IRCCS National Institute, Ancona, Italy.
Fiorella MarcheselliCenter of Clinical Pathology and Innovative Therapy, INRCA-IRCCS National Institute, Ancona, Italy.
Stefano SalvioliDepartment of Experimental, Diagnostic and Specialty Medicine.
Giovanni VitaleCentro di Ricerche e Tecnologie Biomediche, Istituto Auxologico Italiano IRCCS, Cusano Milanino, Italy.
Fabiola OlivieriCenter of Clinical Pathology and Innovative Therapy, INRCA-IRCCS National Institute, Ancona, Italy.
Annemieke M W SpijkermanCentre for Nutrition, Prevention and Health Services.
Martijn E T DolléCentre for Health Protection, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
John M SedivyDepartment of Molecular Biology, Cell Biology and Biochemistry, Center for Genomics and Proteomics, Brown University, Providence, Rhode Island.
Gastone CastellaniDepartment of Physics and Astronomy, University of Bologna, Italy.
Claudio FranceschiDepartment of Experimental, Diagnostic and Specialty Medicine.
Pieternella E SlagboomDepartment of Molecular Epidemiology, Leiden University Medical Center, The Netherlands.
Paolo GaragnaniDepartment of Experimental, Diagnostic and Specialty Medicine.
University of Bologna · ITLeiden University Medical Center · NLIstituto Nazionale di Riposo e Cura per Anziani · ITInstitute of Neurological Sciences · ITMax Planck Institute for Biology of Ageing · DENational Institute for Public Health and the Environment · NLUniversity of Milan · IT

Funding

Somatic Activation of Retrotransposition: A New Molecular Mechanism of Aging?P01AG051449 · NIA · BROWN UNIVERSITY · PI John M Sedivy · 2016 to 2026
$30.4M
Effectors of cellular senescence statesR37AG016694 · NIA · BROWN UNIVERSITY · PI SEDIVY, JOHN M · 2009 to 2018
$3.2M
NIA NIH HHS P01 AG051449NIA NIH HHS R37 AG016694
6 · The paper itself

Abstract

Epigenetic remodeling is one of the major features of the aging process. We recently demonstrated that DNA methylation of ELOVL2 and FHL2 CpG islands is highly correlated with age in whole blood. Here we investigated several aspects of age-associated hypermethylation of ELOVL2 and FHL2. We showed that ELOVL2 methylation is significantly different in primary dermal fibroblast cultures from donors of different ages. Using epigenomic data from public resources, we demonstrated that most of the tissues show ELOVL2 and FHL2 hypermethylation with age. Interestingly, ELOVL2 hypermethylation was not found in tissues with very low replication rate. We demonstrated that ELOVL2 hypermethylation is associated with in vitro cell replication rather than with senescence. We confirmed intra-individual hypermethylation of ELOVL2 and FHL2 in longitudinally assessed participants from the Doetinchem Cohort Study. Finally we showed that, although the methylation of the two loci is not associated with longevity/mortality in the Leiden Longevity Study, ELOVL2 methylation is associated with cytomegalovirus status in nonagenarians, which could be informative of a higher number of replication events in a fraction of whole-blood cells. Collectively, these results indicate that ELOVL2 methylation is a marker of cell divisions occurring during human aging.

Indexed as

AcetyltransferasesAgedAgingCell ProliferationCells, CulturedCellular SenescenceCpG IslandsDNA MethylationEpigenesis, GeneticFatty Acid ElongasesFemaleHumansLIM-Homeodomain ProteinsLongevityLongitudinal StudiesMaleAcetyltransferasesELOVL2 protein, humanFatty Acid ElongasesFHL2 protein, humanLIM-Homeodomain ProteinsMuscle ProteinsTranscription FactorsBiomarkerEpigeneticsFHL2Methylation

Identifiers

PMID27672102
PMCPMC5861890
OpenAlexW2525868901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.